文献速递生殖医学

肥胖远交系小鼠通过饮食正常化或热量限制作为孕前保健干预改善代谢健康和卵母细胞质量仅获得部分益处

Obese outbred mice only partially benefit from diet normalization or calorie restriction as preconception care interventions to improve metabolic health and oocyte quality.
PubMed 文献 · Hum Reprod · 2022-01-01

研究在西方饮食诱导的肥胖远交系瑞士小鼠中比较饮食正常化与30%热量限制2或4周对代谢健康和卵母细胞质量的影响。热量限制组2周后代谢健康和卵母细胞体外发育能力已显著改善,而饮食正常化组2周改善代谢健康、4周改善卵母细胞质量。

要点

  • 热量限制2周即完全恢复胆固醇和胰岛素敏感性,但出现空腹低血糖迹象。
  • 饮食正常化2周恢复体重、血脂和糖耐量,但胰岛素敏感性未改善。
  • 饮食正常化4周改善卵母细胞线粒体超微结构和活性,但体外发育能力未达对照组水平。

核心结论

  • 热量限制组2周后代谢健康和卵母细胞体外发育能力已显著改善,而饮食正常化组2周改善代谢健康、4周改善卵母细胞质量。

研究设计与样本

  • 远交系雌性瑞士小鼠喂食对照(CTRL)或高脂/高糖(HF/HS)饮食7周后分为四组:CTRL_CTRL、HF_HF、HF_CTRL(改为随意对照饮食)和HF_CR(改为30%热量限制对照饮食)干预2或4周。
  • 每个处理组每个时间点n=8只小鼠。

主要发现

  • HF/HS饮食对代谢健康和卵母细胞质量有显著负面影响(P < 0.05)。
  • HF_CTRL组干预2周后体重、血清脂质谱和糖耐量与CTRL_CTRL组相似(与HF_HF组相比P < 0.05),但胰岛素敏感性未改善。
  • HF_CTRL组干预2周时卵母细胞脂滴体积减少(与HF_HF组相比P < 0.05),但线粒体定位和活性仍异常;干预4周时线粒体超微结构异常显著减少且线粒体活性改善(P < 0.05),但脂质含量再次升高,卵母细胞体外发育能力改善但未达CTRL_CTRL组水平。
  • HF_CR组干预2周后胆固醇浓度和胰岛素敏感性完全恢复,其他代谢健康参数仅在干预4周后恢复并出现明显空腹低血糖迹象;尽管所有线粒体参数仍异常,卵母细胞体外发育能力在干预2周后已完全恢复。

临床怎么用

  • 作者认为本研究结果可为制定肥胖代谢受损女性孕前保健指南提供重要基础见解。

局限性

  • 本研究在远交系小鼠模型中使用相关HF/HS西方饮食诱导肥胖,将结果转化到人类时需考虑生理差异。
  • 研究深入随访代谢健康变化并结合与小鼠卵泡发生持续时间(3周)相关的特定PCCI间隔(2和4周),应有助于将发现外推到人类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can diet normalization or a calorie-restricted diet for 2 or 4 weeks be used as a preconception care intervention (PCCI) in Western-type diet-induced obese Swiss mice to restore metabolic health and oocyte quality? SUMMARY ANSWER: Metabolic health and oocyte developmental competence was already significantly improved in the calorie-restricted group after 2 weeks, while obese mice that underwent diet normalization showed improved metabolic health after 2 weeks and improved oocyte quality after 4 weeks. WHAT IS KNOWN ALREADY: Maternal obesity is linked with reduced metabolic health and oocyte quality; therefore, infertile obese women are advised to lose weight before conception to increase pregnancy chances. However, as there are no univocal guidelines and the specific impact on oocyte quality is not known, strategically designed studies are needed to provide fundamental insights in the importance of the type and duration of the dietary weight loss strategy for preconception metabolic health and oocyte quality. STUDY DESIGN, SIZE, DURATION: Outbred female Swiss mice were fed a control (CTRL) or high-fat/high-sugar (HF/HS) diet. After 7 weeks, some of the HF mice were put on two different PCCIs, resulting in four treatment groups: (i) only control diet for up to 11 weeks (CTRL_CTRL), (ii) only HF diet for up to 11 weeks (HF_HF), (iii) switch at 7 weeks from an HF to an ad libitum control diet (HF_CTRL) and (iv) switch at 7 weeks from an HF to a 30% calorie-restricted control diet (HF_CR) for 2 or 4 weeks. Metabolic health and oocyte quality were assessed at 2 and 4 weeks after the start of the intervention (n = 8 mice/treatment/time point). PARTICIPANTS/MATERIALS, SETTING, METHODS: Changes in body weight were recorded. To study the impact on metabolic health, serum insulin, glucose, triglycerides, total cholesterol and alanine aminotransferase concentrations were measured, and glucose tolerance and insulin sensitivity were analyzed at PCCI Weeks 2 and 4. The quality of in vivo matured oocytes was evaluated by assessing intracellular lipid droplet content, mitochondrial activity and localization of active mitochondria, mitochondrial ultrastructure, cumulus cell targeted gene expression and oocyte in vitro developmental competence. MAIN RESULTS AND THE ROLE OF CHANCE: Significant negative effects of an HF/HS diet on metabolic health and oocyte quality were confirmed (P < 0.05). HF_CTRL mice already showed restored body weight, serum lipid profile and glucose tolerance, similar to the CTRL_CTRL group after only 2 weeks of PCCI (P < 0.05 compared with HF_HF) while insulin sensitivity was not improved. Oocyte lipid droplet volume was reduced at PCCI Week 2 (P < 0.05 compared with HF_HF), while mitochondrial localization and activity were still aberrant. At PCCI Week 4, oocytes from HF_CTRL mice displayed significantly fewer mitochondrial ultrastructural abnormalities and improved mitochondrial activity (P < 0.05), while lipid content was again elevated. The in vitro developmental capacity of the oocytes was improved but did not reach the levels of the CTRL_CTRL mice. HF_CR mice completely restored cholesterol concentrations and insulin sensitivity already after 2 weeks. Other metabolic health parameters were only restored after 4 weeks of intervention with clear signs of fasting hypoglycemia. Although all mitochondrial parameters in HF_CR oocytes stayed aberrant, oocyte developmental competence in vitro was completely restored already after 2 weeks of intervention. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: In this study, we applied a relevant HF/HS Western-type diet to induce obesity in an outbred mouse model. Nevertheless, physiological differences should be considered when translating these results to the human setting. However, the in-depth study and follow-up of the metabolic health changes together with the strategic implementation of specific PCCI intervals (2 and 4 weeks) related to the duration of the mouse folliculogenesis (3 weeks), should aid in the extrapolation of our findings to the human setting. WIDER IMPLICATIONS OF THE FINDINGS: Our study results with a specific focus on oocyte quality provide important fundamental insights to be considered when developing preconception care guidelines for obese metabolically compromised women wishing to become pregnant. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Flemish Research Fund (FWO-SB grant 1S25020N and FWO project G038619N). The authors declare there are no conflicts of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Smits A, Marei WFA, Moorkens K, et al. Obese outbred mice only partially benefit from diet normalization or calorie restriction as preconception care interventions to improve metabolic health and oocyte quality. Hum Reprod. 2022. PMID: 36342870. doi:10.1093/humrep/deac226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。